Business Card for Kathy Stupak:


1 Becton Drive
Franklin Lakes, NJ 07417
Tel: (201) 847-6800

Last updated on 2017-10-01

About Kathy Stupak:

Kathy Stupak works as an Controller for Becton Dickinson at NJ, CT. The company's webpage is http://www.bd.com. For email, phone number and executive profiles for Controller and other executives of Becton Dickinson at NJ, CT, check Becton Dickinson at Joesdata.com. Not the Kathy Stupak you are looking for? Do a quick search in our website and find other people named Kathy Stupak.
Kathy Stupak's Work History:
No information available..

Kathy Stupak's Education:
No information available..

Kathy Stupak's Co-workers:
As of May 28, 2022, Kathy Stupak has 278 co-workers under the company name Becton Dickinson at Joesdata.com.

About Becton Dickinson:

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. BD's operations consist of three business segments: BD Medical, BD Diagnostics and BD Biosciences. On February 9, 2012, the Company acquired a 100% interest in KIESTRA Lab Automation BV. On August 24, 2012, the Company acquired a 100% interest in Sirigen Group Limited. On October 31, 2012, the Company sold its BD Biosciences -Discovery Labware unit. In December 2012, the Company acquired Safety Syringes, Inc....... (Source: SEC reports)

Company News:
2018-10-03 18:43:06
Tom Polen Promoted to Chief Operating Officer of BD
2018-08-20 04:40:20
BD Elects Jeffrey Henderson to Board of Directors
2018-06-06 05:18:00
BD Names John DeFord Chief Technology Officer
2017-10-05 20:42:45
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
2017-09-29 20:01:38
Timothy M. Ring and David F. Melcher to Join BD Board of Directors
2017-09-20 20:14:24
BD and Euroclone Announce Development and Global Distribution Agreement for Tests to Detect Emerging Sexually-Transmitted Pathogens
2017-09-08 20:42:55
BD to Present at the Morgan Stanley Global Healthcare Conference 2017
2017-07-25 20:43:24
BD Board Declares Dividend
2017-07-03 21:37:17
BD Announces Extension of Exchange Offers and Consent Solicitations for C. R. Bard, Inc. Notes
2017-06-09 20:43:11
BD and Bard Receive Second Requests from FTC under HSR Act

People in the same industry: